ReviewCurrent treatment options in oncology2023

New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer.

Jamie O Brett et al.PubMed ↗Publisher ↗

No numbers read from the abstract.